These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1233245)

  • 1. A GLC method for estimation of chlorophenoxyisobutyric acid in plasma. Pharmacokinetics of a single oral dose of clofibrate in man.
    Houin G; Thébault JJ; D'Athis P; Tillement JP; Beaumont JL
    Eur J Clin Pharmacol; 1975 Aug; 8(6):433-7. PubMed ID: 1233245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study and bioavailability of three marketed compounds releasing p-chlorophenoxyisobutyric acid (CPIB) in volunteers.
    Harvengt C; Desager JP
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):113-8. PubMed ID: 1002348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A quantitative gaschromatographic method for the determination of p-chlorophenoxyisobutyric acid (clofibrinic acid) in human plasma (author's transl)].
    Häselbarth V
    Arzneimittelforschung; 1976; 26(11):2076-80. PubMed ID: 1037251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofibrate pharmacokinetics: effect of elevation of plasma-free fatty acids.
    Crouthamel WG; Cenedella RJ
    Pharmacology; 1975; 13(5):465-73. PubMed ID: 1208648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid gas chromatographic method for the determination of chlorophenoxyisobutyric acid in plasma and urine.
    Gugler R; Jensen C
    J Chromatogr; 1976 Feb; 117(1):175-9. PubMed ID: 1249148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of cholestyramine on the pharmacokinetics of clofibrate in man.
    Sedaghat A; Ahrens EH
    Eur J Clin Invest; 1975 Apr; 5(2):177-85. PubMed ID: 1149779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man.
    Emudianughe TS; Caldwell J; Sinclair KA; Smith RL
    Drug Metab Dispos; 1983; 11(2):97-102. PubMed ID: 6133730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition pharmacokinetics of bezafibrate in man.
    Abshagen U; Bablok W; Koch K; Lang PD; Schmidt HA; Senn M; Stork H
    Eur J Clin Pharmacol; 1979 Aug; 16(1):31-8. PubMed ID: 499297
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of colestipol hydrochloride on the bioavailability and pharmacokinetics of clofibrate.
    DeSante KA; DiSanto AR; Albert KS; Weber DJ; Welch RD; Vecchio TJ
    J Clin Pharmacol; 1979; 19(11-12):721-5. PubMed ID: 536468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of food on the absorption of the p-chlorophenolic ester of chlorophenoxyisobutyric acid in man.
    Houin G; Shastri RA; Barre J; Pinchon B; Tillement JP
    Br J Clin Pharmacol; 1984 Mar; 17(3):341-5. PubMed ID: 6712867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofibrate and enzymatic induction in man.
    Houin G; Tillement JP
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):150-4. PubMed ID: 649234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high pressure liquid chromatographic determination of p-chlorophenoxyisobutyric acid and its comparison to a GLC and an ultra violet spectrophotometric method.
    Robinson WT; Cosyns L; Kraml M
    Clin Biochem; 1978 Oct; 11(5):214-7. PubMed ID: 729163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous GLC determination of clofibrate and clofibric acid in human plasma.
    Wolf MS; Zimmerman JJ
    J Pharm Sci; 1980 Jan; 69(1):92-3. PubMed ID: 7354454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gas-liquid chromatographic determination of p-chlorophenoxyisobutyric acid and its comparison to an ultra violet method.
    Bruderlein H; Robinson WT; Kraml M; Dvornik D
    Clin Biochem; 1975 Aug; 8(4):261-72. PubMed ID: 1157294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man.
    Pond SM; Graham GG; Wade DN; Sudlow G
    Aust N Z J Med; 1975 Aug; 5(4):324-8. PubMed ID: 52353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probenecid-clofibrate interaction.
    Veenendaal JR; Brooks PM; Meffin PJ
    Clin Pharmacol Ther; 1981 Mar; 29(3):351-8. PubMed ID: 7471606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of p-chlorophenoxyisobutyric acid in blood plasma by gas-liquid chromatography.
    Cuong TC; Tuong A
    J Chromatogr; 1975 Mar; 106(1):97-102. PubMed ID: 239014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug assays with gas-liquid chromatography and optical detection.
    Karmen A; Pritchett T; Lam S
    J Chromatogr; 1981 Nov; 217():247-53. PubMed ID: 7320112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative gas-chromatographic flame-ionization method for p-chlorophenoxyisobutyric acid in human serum and saliva.
    Connor JN; Johnson GF; Solomon HM
    Clin Chem; 1976 Jun; 22(6):884-8. PubMed ID: 1277477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding to plasma lipoproteins of chlorophenoxyisobutyric, tibric and nicotinic acids and their esters: its significance for the mechanism of lipid lowering by clofibrate and related drugs.
    Beaumont JL; Dachet C
    Atherosclerosis; 1976; 25(2-3):255-66. PubMed ID: 188431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.